Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of topiroxostat tablets in gout with hyperuricemia
CTR20251358Phase 2Completed
- Sponsor
- Hebei Huachen Pharmaceutical Group
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiroxostat in gout, hyperuricemia, sponsored by Hebei Huachen Pharmaceutical Group. Started Apr 2025; status: completed.
02
Drugs
topiroxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20251358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251358.